The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cell Dev. Biol.
Sec. Embryonic Development
Volume 13 - 2025 |
doi: 10.3389/fcell.2025.1522094
A zebrafish model of crim1 loss of function has small and misshapen lenses with dysregulated clic4 and fgf1b expression
Provisionally accepted- 1 Cincinnati Children's Hospital Medical Center, Cincinnati, United States
- 2 College of Medicine, University of Cincinnati, Cincinnati, Ohio, United States
- 3 Division of Medical Genetics, Department of Pediatrics, School of Medicine, University of California, San Francisco, San Francisco, California, United States
- 4 Department of Neurological Surgery, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, United States
- 5 Institute for Human Genetics, Medical Center, University of California, San Francisco, San Francisco, California, United States
- 6 Division of Ophthalmic Genetics and Visual Function Branch, National Eye Institute (NIH), Bethesda, Maryland, United States
- 7 Department of Pediatrics, Cumming School fo Medicine, University of Calgary, Calgary, Alberta, Canada
- 8 Department of Ophthalmology, School of Medicine, Stanford University, Palo Atlo, California, United States
- 9 Division of Child Neurology, Department of Neurology and Neurological Sciences, School of Medicine, Stanford University, Stanford, California, United States
- 10 Departments of Genetics, School of Medicine, Stanford University, Stanford, California, United States
- 11 Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, United States
Heterozygous deletions predicting haploinsufficiency for the Cysteine Rich Motor Neuron 1 (CRIM1) gene have been identified in two families with macrophthalmia, colobomatous, with microcornea (MACOM), an autosomal dominant trait. Crim1 encodes a type I transmembrane protein that is expressed at the cell membrane of lens epithelial and fiber cells at the stage of lens pit formation. Decreased Crim1 expression in the mouse reduced the number of lens epithelial cells and caused defective adhesion between lens epithelial cells and between the epithelial and fiber cells. We present three patients with heterozygous deletions and truncating variants predicted to result in haploinsufficiency for CRIM1 as further evidence for the role of this gene in eye defects, including retinal coloboma, optic pallor, and glaucoma. We used Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 to make a stable Danio rerio model of crim1 deficiency, generating zebrafish that were homozygous for a 2 basepair deletion, c.339_340delCT p.Leu112Leufs*3, in crim1. Homozygous, crim1 -/-larvae demonstrated smaller eyes and small and misshapen lenses compared to controls, but we did not observe colobomas. Bulk RNA-Seq using dissected eyes from crim1 -/-larvae and controls at 72 hours post fertilization showed significant downregulation of crim1 and chloride intracellular channel 4 (clic4) and upregulation of fibroblast growth factor 1b (fgf1b) and complement component 1, q subcomponent (c1q), amongst other dysregulated genes. Our work strengthens the association between haploinsufficiency for CRIM1 and eye defects and characterizes a stable model of crim1 loss of function for future research.
Keywords: CRIM1, Zebrafish, Lens development, RNA-Seq, MACOM, Coloboma, macrophthalmia
Received: 03 Nov 2024; Accepted: 22 Jan 2025.
Copyright: © 2025 Slavotinek, Le, Htun, Pandey, Sun, Magnusen, Ullah, Lauzon, Beres, Lee, Guan, Hufnagel, Brooks and Baranzini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Anne Slavotinek, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.